Tower Research Capital LLC (Trc) Infla Rx N.V. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.47 - $2.03 $3,741 - $5,166	2,545 Added 42.98%	8,466 $13,000
Q4 2023 Feb 13, 2024	SELL	$1.25 - $2.75 $2,626 - $5,777	-2,101 Reduced 26.19%	5,921 $9,000
Q3 2023 Nov 14, 2023	BUY	$2.66 - $4.33 $16,340 - $26,599	6,143 Added 326.93%	8,022 $23,000
Q2 2023 Aug 14, 2023	SELL	$2.05 - $6.1 $5,672 - $16,878	-2,767 Reduced 59.56%	1,879 $8,000
Q1 2023 May 09, 2023	BUY	$1.66 - $3.1 $4,329 - $8,084	2,608 Added 127.97%	4,646 $9,000
Q4 2022 Feb 10, 2023	SELL	$2.11 - $3.25 $1,276 - $1,966	-605 Reduced 22.89%	2,038 $6,000
Q3 2022 Nov 10, 2022	SELL	$1.32 - $3.14 $1,479 - $3,519	-1,121 Reduced 29.78%	2,643 $7,000
Q2 2022 Aug 15, 2022	BUY	$0.78 - $1.9 $2,935 - $7,151	3,764 New	3,764 $5,000
Q1 2022 May 12, 2022	SELL	$1.83 - $4.48 $422 - $1,034	-231 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.35 - $5.58 $542 - $1,288	231 New	231 $1,000
Q1 2021 May 17, 2021	SELL	$3.62 - $6.34 $16,615 - $29,100	-4,590 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.82 - $5.32 $10,077 - $14,034	2,638 Added 135.14%	4,590 $23,000
Q3 2020 Nov 16, 2020	SELL	$3.7 - $5.47 $458 - $678	-124 Reduced 5.97%	1,952 $9,000
Q2 2020 Aug 13, 2020	BUY	$4.59 - $8.96 $8,321 - $16,244	1,813 Added 689.35%	2,076 $10,000
Q1 2020 May 15, 2020	SELL	$2.65 - $6.08 $26,266 - $60,264	-9,912 Reduced 97.42%	263 $1,000
Q4 2019 Feb 07, 2020	BUY	$2.2 - $4.54 $19,170 - $39,561	8,714 Added 596.44%	10,175 $41,000
Q3 2019 Nov 05, 2019	SELL	$2.47 - $3.51 $4,043 - $5,745	-1,637 Reduced 52.84%	1,461 $4,000
Q2 2019 Aug 13, 2019	BUY	$3.06 - $51.61 $6,866 - $115,812	2,244 Added 262.76%	3,098 $10,000
Q1 2019 May 14, 2019	BUY	$31.16 - $48.62 $8,008 - $12,495	257 Added 43.05%	854 $32,000
Q4 2018 Feb 14, 2019	SELL	$23.33 - $36.37 $77,175 - $120,311	-3,308 Reduced 84.71%	597 $22,000
Q3 2018 Nov 13, 2018	BUY	$29.34 - $35.0 $30,748 - $36,680	1,048 Added 36.68%	3,905 $134,000
Q2 2018 Aug 15, 2018	BUY	$27.33 - $41.46 $9,100 - $13,806	333 Added 13.19%	2,857 $92,000
Q1 2018 May 15, 2018	BUY	$20.21 - $32.0 $43,390 - $68,704	2,147 Added 569.5%	2,524 $73,000
Q4 2017 Feb 09, 2018	BUY	$14.55 - $23.99 $5,485 - $9,044	377	377 $8,000

Others Institutions Holding IFRX

# of Institutions

Shares Held

12.9M

Call Options Held

19.3K

Put Options Held

Suvretta Capital Management, LLC New York, NY

5.73M
Shares

$10 Million
0.35% of portfolio
683 Capital Management, LLC New York, NY

2.07M
Shares

$3.62 Million
0.29% of portfolio
Eversept Partners, LP New York, NY

1.62M
Shares

$2.84 Million
0.2% of portfolio
Ubs Oconnor LLC Chicago, IL

798K
Shares

$1.4 Million
0.08% of portfolio
Ikarian Capital, LLC Dallas, TX

705K
Shares

$1.23 Million
0.19% of portfolio

View Full List

About InflaRx N.V.

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $77.4M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

More about IFRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account